Manager, Accounting
AVENZO THERAPEUTICS INC
Summary
Reporting to the Associate Director, Assistant Controller, the Manager, Accounting will play a key role in managing the Company's accounting operations and ensuring accurate, timely, and compliant financial reporting. This role partners closely with the Assistant Controller and cross-functional teams to support a fast-paced, clinical stage biotech environment, including general accounting, accounts payable, and compliance with Generally Accepted Accounting Principles (GAAP) and internal controls.
Job description
Position Summary
Reporting to the Associate Director, Assistant Controller, the Manager, Accounting will play a key role in managing the Company's accounting operations and ensuring accurate, timely, and compliant financial reporting. This role partners closely with the Assistant Controller and cross-functional teams to support a fast-paced, clinical stage biotech environment, including general accounting, accounts payable, and compliance with Generally Accepted Accounting Principles (GAAP) and internal controls.
Essential Job Functions and Responsibilities
- Manage day-to-day accounting operations, including general ledger activities, journal entries, account reconciliations, and financial statement preparation
- Oversee the Accounts Payable function including invoice processing, expense reporting and payment runs, ensuring accuracy and compliance with company policies and internal controls
- Maintain and review supporting schedules, journal entry documentation and account reconciliations to ensure accuracy, completeness, and audit readiness
- Support the Assistant Controller in executing monthly, quarterly, and annual close processes, ensuring timely and accurate financial reporting in accordance with U.S. GAAP
- Review the general ledger activity to ensure accuracy, completeness and appropriate account classification
- Review purchase requisitions, purchase orders, contracts, and statements of work to ensure expenses are recorded in the appropriate accounts and controls
- Support compliance with Sarbanes-Oxley (SOX) internal controls, public company reporting requirements and external audit requests
- Review vendor invoices and expense reports for accuracy and compliance to company policy
- Evaluate accounting systems, processes, and workflows to improve efficiency, accuracy, and scalability
- Partner with the Assistant Controller and cross-functional teams to support accounting operations, financial reporting and internal control requirements deadlines
Preferred Qualifications
- Bachelor's degree in Accounting or Finance required, or a related area degree preferred (e.g., MBA) with 8+ years of progressive accounting experience in the life sciences industry or an equivalent combination of academic and industry experience
- CPA strongly preferred, not required
- Strong understanding of GAAP, SOX and financial reporting principles
- Hands-on experience with general ledger accounting, account reconciliations, journal entries, and financial close processes
- Strong attention to detail with a demonstrated commitment to accuracy, completeness, and integrity in financial reporting and accounting activities
- Ability to independently manage multiple priorities and deadlines
- Exercises strong judgment and integrity. Highly motivated to take on increasing responsibilities, learn quickly and grow with the opportunities created by a fast-moving environment
- Experience with an ERP system such as NetSuite and procure-to-pay platforms
- Excellent communication and interpersonal skills, with the ability to collaborate effectively with internal and external stakeholders
- Strong analytical and problem-solving abilities, with a strategic mindset
- This position requires periodic/regular travel, including up to 5% of work time, which may include overnight travel
Requirements
- Bachelor's degree in Accounting or Finance required
- 8+ years of progressive accounting experience in the life sciences industry or equivalent combination of academic and industry experience
- CPA strongly preferred, not required
- Strong understanding of GAAP, SOX and financial reporting principles
- Hands-on experience with general ledger accounting, account reconciliations, journal entries, and financial close processes
- Strong attention to detail and commitment to accuracy, completeness, and integrity
- Ability to independently manage multiple priorities and deadlines
- Experience with an ERP system such as NetSuite and procure-to-pay platforms
- Excellent communication and interpersonal skills
- Strong analytical and problem-solving abilities with a strategic mindset
- Periodic/regular travel up to 5% of work time
Benefits
- Medical, Dental & Vision
- Basic Life & AD&D Insurance
- Short & Long-Term Disability
- Flexible Spending Accounts
- Health Savings Accounts
- Voluntary Life & AD&D
- Critical Illness Insurance
- 401(k) Plan
- Paid Vacation Time
- Paid Sick Leave
- 17 Paid Holidays
- Winter Closure
- Annual Discretionary Bonus
- Equity Award
Company overview
Avenzo Therapeutics is a clinical-stage biotechnology company founded in 2022 and headquartered in San Diego, California, dedicated to developing the next generation of oncology therapies to transform cancer treatment. The company focuses on creating potentially best-in-class or first-in-class targeted therapies for solid tumors and cancers with high unmet medical needs. Avenzo's pipeline includes innovative antibody-drug conjugates (ADCs) and selective kinase inhibitors targeting validated oncology pathways, with multiple programs currently in Phase 1/2 clinical development. The company was founded by experienced oncology drug development veterans, including CEO Athena Countouriotis, M.D., who previously led Turning Point Therapeutics through its successful acquisition by Bristol Myers Squibb. Avenzo has raised significant venture capital funding, including a $60 million Series B round in 2025, and is backed by prominent investors including OrbiMed, SR One, and Lilly Asia Ventures. The company's approach combines deep oncology expertise with strategic in-licensing of promising assets to build a diversified portfolio of targeted cancer therapies.